Horowitz AT - Search Results

1

In vitro cytotoxicity of liposome-encapsulated doxorubicin: dependence on liposome composition and drug release.

Horowitz AT, Barenholz Y, Gabizon AA. Horowitz AT, et al. Biochim Biophys Acta. 1992 Aug 24;1109(2):203-9. doi: 10.1016/0005-2736(92)90084-y. Biochim Biophys Acta. 1992. PMID: 1520697

2

Doxorubicin encapsulated in sterically stabilized liposomes for the treatment of a brain tumor model: biodistribution and therapeutic efficacy.

Siegal T, Horowitz A, Gabizon A. Siegal T, et al. J Neurosurg. 1995 Dec;83(6):1029-37. doi: 10.3171/jns.1995.83.6.1029. J Neurosurg. 1995. PMID: 7490617

3

Liposome longevity and stability in circulation: effects on the in vivo delivery to tumors and therapeutic efficacy of encapsulated anthracyclines.

Gabizon A, Chemla M, Tzemach D, Horowitz AT, Goren D. Gabizon A, et al. Among authors: horowitz at. J Drug Target. 1996;3(5):391-8. doi: 10.3109/10611869608996830. J Drug Target. 1996. PMID: 8866658

4

Targeting of stealth liposomes to erbB-2 (Her/2) receptor: in vitro and in vivo studies.

Goren D, Horowitz AT, Zalipsky S, Woodle MC, Yarden Y, Gabizon A. Goren D, et al. Among authors: horowitz at. Br J Cancer. 1996 Dec;74(11):1749-56. doi: 10.1038/bjc.1996.625. Br J Cancer. 1996. PMID: 8956788 Free PMC article.

5

Nuclear delivery of doxorubicin via folate-targeted liposomes with bypass of multidrug-resistance efflux pump.

Goren D, Horowitz AT, Tzemach D, Tarshish M, Zalipsky S, Gabizon A. Goren D, et al. Among authors: horowitz at. Clin Cancer Res. 2000 May;6(5):1949-57. Clin Cancer Res. 2000. PMID: 10815920

6

Dose dependency of pharmacokinetics and therapeutic efficacy of pegylated liposomal doxorubicin (DOXIL) in murine models.

Gabizon A, Tzemach D, Mak L, Bronstein M, Horowitz AT. Gabizon A, et al. Among authors: horowitz at. J Drug Target. 2002 Nov;10(7):539-48. doi: 10.1080/1061186021000072447. J Drug Target. 2002. PMID: 12683721

7

In vivo fate of folate-targeted polyethylene-glycol liposomes in tumor-bearing mice.

Gabizon A, Horowitz AT, Goren D, Tzemach D, Shmeeda H, Zalipsky S. Gabizon A, et al. Among authors: horowitz at. Clin Cancer Res. 2003 Dec 15;9(17):6551-9. Clin Cancer Res. 2003. PMID: 14695160

8

Tumor cell targeting of liposome-entrapped drugs with phospholipid-anchored folic acid-PEG conjugates.

Gabizon A, Shmeeda H, Horowitz AT, Zalipsky S. Gabizon A, et al. Among authors: horowitz at. Adv Drug Deliv Rev. 2004 Apr 29;56(8):1177-92. doi: 10.1016/j.addr.2004.01.011. Adv Drug Deliv Rev. 2004. PMID: 15094214 Review.

9

Reduced toxicity and superior therapeutic activity of a mitomycin C lipid-based prodrug incorporated in pegylated liposomes.

Gabizon AA, Tzemach D, Horowitz AT, Shmeeda H, Yeh J, Zalipsky S. Gabizon AA, et al. Among authors: horowitz at. Clin Cancer Res. 2006 Mar 15;12(6):1913-20. doi: 10.1158/1078-0432.CCR-05-1547. Clin Cancer Res. 2006. PMID: 16551877

10

Pharmacological studies of cisplatin encapsulated in long-circulating liposomes in mouse tumor models.

Bandak S, Goren D, Horowitz A, Tzemach D, Gabizon A. Bandak S, et al. Anticancer Drugs. 1999 Nov;10(10):911-20. doi: 10.1097/00001813-199911000-00007. Anticancer Drugs. 1999. PMID: 10630359

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

28 results

Search Page

Filters